These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Some thoughts on individual bioequivalence. Liu J; Chow SC J Biopharm Stat; 1997 Mar; 7(1):41-8. PubMed ID: 9056587 [No Abstract] [Full Text] [Related]
3. Bioequivalence: the regulatory career of a pharmaceutical concept. Carpenter D; Tobbell DA Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918 [TBL] [Abstract][Full Text] [Related]
4. Assessing individual bioequivalence using the structural equation model. Carrasco JL; Jover L Stat Med; 2003 Mar; 22(6):901-12. PubMed ID: 12627408 [TBL] [Abstract][Full Text] [Related]
5. A modified large sample approach in the assessment of population bioequivalence. Quiroz J; Ting N; Wei GC; Burdick RK J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391 [TBL] [Abstract][Full Text] [Related]
6. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs. Quiroz J; Ting N; Wei GC; Burdick RK Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892 [TBL] [Abstract][Full Text] [Related]
8. On TIER method for assessment of individual bioequivalence. Ju HL J Biopharm Stat; 1997 Mar; 7(1):63-85. PubMed ID: 9056589 [TBL] [Abstract][Full Text] [Related]
9. Mean difference vs. variability reduction: tradeoffs in aggregate measures for individual bioequivalence. FDA Individual Bioequivalence Working Group. Hauck WW; Chen ML; Hyslop T; Patnaik R; Schuirmann D; Williams R Int J Clin Pharmacol Ther; 1996 Dec; 34(12):535-41. PubMed ID: 8996848 [TBL] [Abstract][Full Text] [Related]
10. Striving for standards in bioequivalence assessment: a review. Schulz HU; Steinijans VW Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):293-8. PubMed ID: 1743802 [No Abstract] [Full Text] [Related]
11. Bayesian approach to average bioequivalence using Bayes' factor. Ghosh P; Khattree R J Biopharm Stat; 2003 Nov; 13(4):719-34. PubMed ID: 14584718 [TBL] [Abstract][Full Text] [Related]
12. Levothyroxine and FDA bioequivalence ratings. Fox GN J Fam Pract; 2005 Feb; 54(2):179. PubMed ID: 15689298 [No Abstract] [Full Text] [Related]
17. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability. Bialer M; Midha KK Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761 [TBL] [Abstract][Full Text] [Related]
18. Extension to the use of tolerance intervals for the assessment of individual bioequivalence. Esinhart JD; Chinchilli VM J Biopharm Stat; 1994 Mar; 4(1):39-52. PubMed ID: 8019583 [TBL] [Abstract][Full Text] [Related]
19. Bioequivalence/bioavailability retention samples. Ransom C Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218 [No Abstract] [Full Text] [Related]